loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 1fe10df7 F710 419d 9035 3b4936ada303 Applno 21055 Form Capsule Oral Dosage 75mg - Drug Product Composition: Bexarotene

    Menu

    Bexarotene

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12,273Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21055 / DOSAGE - CAPSULE;ORAL - 75MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BEXAROTENE(UNII: A61RXM4375)
    (BEXAROTENE - UNII:A61RXM4375)     		BEXAROTENE75mg

    Inactive Ingredients

    Ingredient Name
    Bausch Health US, LLC
    Eisai Inc.
    Mylan Institutional Inc.
    1,4-SORBITAN(AV0YTZ4E6J) 
    BUTYLATED HYDROXYANISOLE(REK4960K2U)
    CROSPOVIDONE(2S7830E561)  
    FERROSOFERRIC OXIDE(XM0M87F357)  
    GELATIN(2G86QN327L)  
    GELATIN, UNSPECIFIED(2G86QN327L) 
    GLYCERIN(PDC6A3C0OX)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)  
    MANNITOL(3OWL53L36A) 
    POLYETHYLENE GLYCOL 400(B697894SGQ)
    POLYSORBATE 20(7T1F30V5YH)
    POVIDONE(FZ989GH94E)  
    POVIDONE, UNSPECIFIED(FZ989GH94E)  
    SORBITOL(506T60A25R)
    TITANIUM DIOXIDE(15FIX9V2JP)
    WATER(059QF0KO0R)